China Universal Asset Management Co., Ltd. Bio Atla, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$773 Million
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$1.7 - $3.07 $1,009 - $1,823	594 Added 95.04%	1,219 $2,000
Q3 2023 Oct 30, 2023	BUY	$1.7 - $3.07 $1,009 - $1,823	594 Added 95.04%	1,219 $2,000
Q2 2023 May 21, 2024	SELL	$2.83 - $3.87 $2 - $3	-1 Reduced 0.16%	625 $1,000
Q2 2023 Jul 27, 2023	SELL	$2.83 - $3.87 $2 - $3	-1 Reduced 0.16%	625 $2,000
Q1 2023 May 21, 2024	BUY	$2.3 - $8.25 $361 - $1,295	157 Added 33.48%	626 $1,000

Q1 2023 Apr 27, 2023	BUY	$2.3 - $8.25 $361 - $1,295	157 Added 33.48%	626 $2,000
Q4 2022 May 21, 2024	BUY	$7.63 - $11.01 $3,578 - $5,163	469 New	469 $3,000
Q4 2022 Jan 31, 2023	BUY	$7.63 - $11.01 $984 - $1,420	129 Added 37.94%	469 $4,000
Q3 2022 Oct 21, 2022	BUY	$2.94 - $11.87 $999 - $4,035	340 New	340 $3,000

Others Institutions Holding BCAB

# of Institutions

Shares Held

24.8M

Call Options Held

140K

Put Options Held

4.6K

Soleus Capital Management, L.P. Greenwich, CT

4.07M
Shares

$5.37 Million
1.14% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$3.67 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$2.77 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.91M
Shares

$2.52 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

1.47M
Shares

$1.95 Million
0.62% of portfolio

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $47.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account